CRIS Current Research Information System

TAVOLARI, SIMONA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.457
AS - Asia 3.036
EU - Europa 2.336
AF - Africa 245
SA - Sud America 148
OC - Oceania 3
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.227
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.426
SG - Singapore 973
CN - Cina 965
VN - Vietnam 453
GB - Regno Unito 443
IT - Italia 387
SE - Svezia 328
DE - Germania 282
HK - Hong Kong 199
IN - India 150
CH - Svizzera 135
KR - Corea 135
IE - Irlanda 130
FR - Francia 112
RU - Federazione Russa 99
BR - Brasile 96
NL - Olanda 90
UA - Ucraina 79
FI - Finlandia 73
CI - Costa d'Avorio 62
TG - Togo 55
SC - Seychelles 51
ZA - Sudafrica 39
JO - Giordania 36
BE - Belgio 33
JP - Giappone 32
NG - Nigeria 28
ID - Indonesia 27
EE - Estonia 26
BG - Bulgaria 24
CA - Canada 24
AR - Argentina 17
AT - Austria 17
PL - Polonia 17
GR - Grecia 11
HR - Croazia 11
CL - Cile 10
EC - Ecuador 10
TR - Turchia 9
RO - Romania 8
IR - Iran 7
LT - Lituania 6
PK - Pakistan 6
PS - Palestinian Territory 6
UZ - Uzbekistan 6
BD - Bangladesh 5
CO - Colombia 5
ES - Italia 5
MX - Messico 5
PH - Filippine 5
PT - Portogallo 5
MY - Malesia 4
PE - Perù 4
PY - Paraguay 4
TN - Tunisia 4
AU - Australia 3
DK - Danimarca 3
SA - Arabia Saudita 3
SI - Slovenia 3
AE - Emirati Arabi Uniti 2
HU - Ungheria 2
IL - Israele 2
IQ - Iraq 2
LB - Libano 2
RS - Serbia 2
TH - Thailandia 2
TW - Taiwan 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AQ - Antartide 1
BB - Barbados 1
BH - Bahrain 1
BY - Bielorussia 1
CG - Congo 1
CZ - Repubblica Ceca 1
EG - Egitto 1
GI - Gibilterra 1
KE - Kenya 1
KW - Kuwait 1
KZ - Kazakistan 1
MC - Monaco 1
NE - Niger 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SV - El Salvador 1
VE - Venezuela 1
Totale 9.227
Salva come PNG Salva come JPEG
Città #
Singapore 676
Chandler 379
Southend 369
Ashburn 368
Hefei 325
Dallas 294
Fairfield 245
Dong Ket 213
Hong Kong 198
Houston 151
Santa Clara 143
Dublin 130
Bologna 128
Seoul 128
Bern 125
Beijing 119
Princeton 115
Wilmington 115
Ann Arbor 108
Woodbridge 108
Seattle 99
Boardman 91
Cambridge 90
Ho Chi Minh City 82
Abidjan 62
New York 60
Hanoi 55
Helsinki 55
Lomé 55
Jacksonville 47
Los Angeles 43
Nanjing 42
Frankfurt am Main 38
Westminster 38
Amman 35
Berlin 34
Bengaluru 33
Tokyo 31
Brussels 30
Padova 30
Redondo Beach 28
Buffalo 27
Jinan 27
Milan 27
Redmond 26
Rome 26
San Diego 25
Sofia 24
Jakarta 23
Guangzhou 20
Medford 18
Abeokuta 17
Shenyang 17
London 16
Munich 15
Changsha 14
Chicago 14
Mülheim 14
São Paulo 14
Turin 14
Lappeenranta 13
Shanghai 13
Tongling 13
Zhengzhou 13
Florence 12
Hebei 12
Phoenix 12
San Francisco 12
Toronto 12
Fremont 11
Jiaxing 11
Des Moines 10
Kuban 10
Nanchang 10
Saint Petersburg 10
Warsaw 10
Nuremberg 9
Olalla 9
Vienna 9
Amsterdam 8
Bühl 8
Da Nang 8
Dearborn 8
Haiphong 8
Montreal 8
Norwalk 8
Redwood City 8
Falkenstein 7
Groningen 7
Haikou 7
Orem 7
Tianjin 7
Council Bluffs 6
Denver 6
Falls Church 6
Halhul 6
Hyderabad 6
Lauterbourg 6
Mountain View 6
Mumbai 6
Totale 6.251
Salva come PNG Salva come JPEG
Nome #
Adjuvant treatment in biliary tract cancer 317
Specific Toxicity of Maintenance Olaparib Versus Placebo in Advanced Malignancies: A Systematic Review and Meta-analysis 272
Antiprotease strategy in combination with gemcitabine as a putative novel therapeutic approach for pancreatic cancer treatment 216
Antitumoral efficacy of the protease inhibitor gabexate mesilate in colon cancer cells harbouring KRAS, BRAF and PIK3CA mutations 215
Antiprotease strategy in pancreatic cancer treatment: emergence from a preclinical study. 210
Membrane human equilibrative nucleoside transporter 1 is associated with a high proliferation rate and worse survival in resected intrahepatic cholangiocarcinoma patients not receiving adjuvant treatments 205
Antitumoral Efficacy of Two Turmeric Extracts According to Different Extraction Methods in Hepatocellular Carcinoma Cell Lines 205
Simple and dendritic cyclam derivative. Photophysical properties, effect of protonation and Zn++ coordination, preliminary screening as inhibitors of tumor cell growth 199
Membrane localization of human equilibrative nucleoside transporter 1 in tumor cells may predict response to adjuvant gemcitabine in resected cholangiocarcinoma patients 198
Asbestos exposure as an additional risk factor for small duct intrahepatic cholangiocarcinoma: a pilot study 192
219 MiR-21 expression correlates with prognosis in extrahepatic radically resected cholangiocarcinomas treated with gemcitabine-based adjuvant chemotherapy 189
How to choose between percutaneous transhepatic and endoscopic biliary drainage in malignant obstructive jaundice: An updated systematic review and meta-analysis 182
Percutaneous radiofrequency ablation in intrahepatic cholangiocarcinoma: a retrospective single-center experience 179
Second-line treatment in advanced biliary tract cancer: Today and tomorrow 176
Licofelone, a dual COX/5-LOX inhibitor, induces apoptosis in HCA-7 colon cancer cells through the mitochondrial pathway independently from its ability to affect the arachidonic acid cascade. 175
The (Eternal) Debate on Microwave Ablation Versus Radiofrequency Ablation in BCLC-A Hepatocellular Carcinoma 175
Angiogenesis modulation in human umbilical endothelial vein (HUVE) cells by selected polychlorobiphenyls congeners is mediated by estrogen receptor alpha (ERα) binding. 174
INTRAHEPATIC CHOLANGIOCARCINOMA DEVELOPMENT IN A PATIENT WITH A NOVEL BAP1 GERMLINE MUTATION AND LOW EXPOSURE TO ASBESTOS 173
In Reply 171
Anti-EGFR monoclonal antibodies in advanced biliary tract cancer: A systematic review and meta-analysis 170
Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies 165
IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland 164
Molecular and proteomic insight into Notch1 characterization in hepatocellular carcinoma 162
Selected polychlorobiphenyls congeners bind to estrogen receptor alpha in human umbilical vascular endothelial (HUVE) cells modulating angiogenesis 161
Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumour Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes 157
Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner 156
Annellated pyrrole compounds for cancer management 155
The decrease of cell membrane fluidity by the non-steroidal anti-inflammatory drug Licofelone inhibits epidermal growth factor receptor signalling and triggers apoptosis in HCA-7 colon cancer cells. 155
Genetic heterogeneity in cholangiocarcinoma: a major challenge for targeted therapies 150
Intensive follow-up program and oncological outcomes of 278 biliary tract cancer patients after curative intent surgery: A single-center retrospective experience 147
Immunomodulation by 17beta-estradiol in bivalve hemocytes. 146
Annellated pyrrole compounds for cancer management 145
The basal-like breast carcinoma phenotype is regulated by SLUG gene expression 145
Cholangiocarcinoma: Epidemiology and risk factors 142
MiR-122/Cyclin G1 Interaction Modulates p53 Activity and Affects Doxorubicin Sensitivity of Human Hepatocarcinoma Cells. 139
Plasma membrane localization of human equilibrative nucleoside transporter 1 (hENT-1) to predict better outcome of adjuvant gemcitabine in cholangiocarcinoma (CC) patients. 137
Genomic And Genetic Characterization of Cholangiocarcinoma Identifies Therapeutics Targets for Tyrosine Kinase Inhibitors 136
Exposure to Asbestos and Increased Intrahepatic Cholangiocarcinoma Risk: Growing Evidences of a Putative Causal Link 134
Re: Effect of simvastatin on cetuximab resistance in human colorectal cancer with KRAS mutations. 131
Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes 131
Effect of the serine proteases inhibitor gabexate mesylate (GM) on the activity of gemcitabine (G) in cell lines of pancreatic cancer (PC) 129
The Protease Inhibitor Gabexate Mesylate Reduces Invasiveness and Angiogenesis in Pancreatic Cancer Cell Lines, Enhancing Gemcitabine Action 125
Wilson disease, ABCC2 c.3972C > T polymorphism and primary liver cancers: suggestions from a familial cluster 124
Decreasing Albumin mRNA Expression in Cholangiocarcinomas along the Bile Duct Tree. 121
Intestinal Microbiota Increases Cell Proliferation of Colonic Mucosa in Human-Flora-Associated (HFA) Mice 120
Is post-transplant chemotherapy feasible in liver transplantation for colorectal cancer liver metastases? 119
IN VIVO/IN VITRO AGED FIBROBLASTS TRIGGER MALIGNANT FEATURES IN NORMAL AND CANCER STEM/PROGENITOR CELLS OF THE MAMMARY GLAND 114
Plasma membrane localization of human equilibrative nucleoside transporter 1 (hENT-1) predicts better outcome of adjuvant gemcitabine in cholangiocarcinoma (CC) patients. 106
Are FGFR and IDH1-2 alterations a positive prognostic factor in intrahepatic cholangiocarcinoma? An unresolved issue 105
The protease inhibitor gabexate Mesylate has antitumor effects and enhances gemcitabine action on pancreatic cancer cell lines 100
Improvements in Systemic Therapies for Advanced Malignant Mesothelioma 99
null 99
Molecular features and targeted therapies in extrahepatic cholangiocarcinoma: Promises and failures 98
Carcinogenesis of Cholangiocarcinoma 97
TUSC3 accelerates cancer growth and induces epithelial-mesenchymal transition by upregulating claudin-1 in non-small-cell lung cancer cells 93
Asbestos and Intrahepatic Cholangiocarcinoma 88
Nivolumab: an investigational agent for the treatment of biliary tract cancer 86
Targeting BRAF-Mutant Biliary Tract Cancer: Recent Advances and Future Challenges 83
Mutational Landscape of Cholangiocarcinoma According to Different Etiologies: A Review 82
Evolution of the experimental models of cholangiocarcinoma 81
Circulating tumor DNA in biliary tract cancer: Current evidence and future perspectives 71
Have We Found the “Holy Grail” That May Predict Response to Immunotherapy in Hepatocellular Carcinoma? 64
TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype. 63
Long Noncoding RNA SBF2-AS1 Is Critical for Tumorigenesis of Early-Stage Lung Adenocarcinoma 63
Current and novel therapeutic opportunities for systemic therapy in biliary cancer 63
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions. 60
Case Report: Long lasting response with TKI for combined hepatocellular-cholangiocarcinoma 30
Classic versus innovative strategies for immuno-therapy in pancreatic cancer 19
Totale 9.453
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.421
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.421
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021480 0 0 0 0 0 33 22 40 69 36 35 245
2021/20221.143 100 35 63 83 75 39 26 57 109 95 234 227
2022/20231.586 166 232 91 186 99 108 31 99 250 41 103 180
2023/2024422 54 59 22 34 34 97 14 25 10 31 15 27
2024/20251.666 70 209 163 122 199 82 112 51 30 139 133 356
2025/20262.550 430 558 586 341 427 208 0 0 0 0 0 0
Totale 9.453